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Background: Inadequate description of patients with cancer receiving palliative care in 
research studies often leads to results having limited generalizability. The need to standardize 
the description of the sample led to the development of the European Association for 
Palliative Care (EAPC) Basic Dataset consisting of 31 core demographic and disease-related 
variables, divided between a patient form and a health care personnel form. 
Aim: To pilot-test the dataset to check acceptability, look for possible sources of error or 
shortcomings, and identify possible needs for changes. 
Design: International multi-centre pilot study at 9 study sites in 5 European countries. Mixed 
methods were used. 
Setting/Participants: Adult cancer patients and staff in palliative care units, hospices, and one 
municipal home care service.  
Results: 191 patients (544 screened) and 190 health care personnel were included. Median 
time to fill in the patient form was 5 minutes, the health care personnel form 7 minutes. 
Ethnicity was the most challenging item for patients and requires decisions at a national level 
about whether or how to include. Health care personnel found weight loss, principal 
diagnosis, additional diagnoses, and stage of non-cancer diseases most difficult to respond to. 
Registration of diagnoses will be changed from ICD-10 code to a predefined list, while weight 
loss and stage of non-cancer diseases will be removed. The pilot study has led to rewording of 
items, improvement in response options, and shortening of the dataset to 29 items. 
Conclusion: Pilot testing of the first version of the EAPC Basic Dataset confirmed that 
patients and health care personnel understand the questions in a consistent manner and can 
answer within an acceptable timeframe. The pilot testing has led to improvement and the new 
version is now subject to further testing. 
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What is already known about the topic?  
There is a need to standardize the description of a palliative care cancer patient population. 
The EAPC Basic Dataset has been developed to standardize research reporting.  
The dataset is a combination of patient reported outcome measures (PROMs) and disease 
related variables recorded by health care personnel. 
 
What this paper adds?  
The first version of the EAPC Basic Dataset has been quality assured through thorough and 
systematic pre-testing in the two target groups, patients and health care personnel, across five 
European countries. 
Pilot-testing has led to a shortened dataset with better clarity and more suitable response 
options. 
 
Implication for practice, theory or policy  
The resulting EAPC Basic Dataset is an international, consensus-based, quality assured tool 
that may increase external validity of research results. Further testing will make this tool a 
more robust standardized research reporting dataset. 
  
Introduction 
Are these findings relevant for my own patients? This is a question all clinicians should ask 
after having read a report on a clinical study within their field. Palliative care is no exception, 
and palliative care populations are even more heterogeneous than in many other areas of 
medicine. Within the palliative care cancer population, differences in patient characteristics 
such as cancer diagnosis, disease status, symptoms, physical functioning, cancer-directed 
treatment, and estimated survival, as well as differences in the organisation and delivery of 
services, are a major concern when considering both applicability and generalizability of 
research findings 1-5. These challenges call for uniform standards on how to describe the 
population and the setting of the study. 
Four literature reviews have examined how palliative care populations were described in 
research reports 6-9. All four concluded that the populations were inconsistently and 
insufficiently described. The authors highlighted the need for a set of common descriptors to 
be used when reporting sample characteristics, a need also acknowledged in several other 
publications 10-14. 
As a response to this, the European Palliative Care Research Centre (PRC) 15 in collaboration 
with the European Association for Palliative Care Research Network (EAPC-RN) 16 and the 
EU-funded PRISMA project 17 launched a project to develop and reach consensus on a basic 
set of variables to describe a palliative care cancer population. Through an international 
Delphi process of five rounds, consensus was reached on a set of 31 core variables (the first 
version of the EAPC Basic Dataset) to be used to describe a palliative care cancer population 
in research, and on how the variables should be measured and recorded 18 (Figure 1). 
The aim of the present study was to pilot test the first version of the EAPC Basic Dataset in 
palliative care cancer patients and health care personnel to assess its acceptability, 







Study design and setting 
This was an international multi-centre study using pre-testing survey procedures combining 
quantitative and qualitative methods 19, 20, conducted at the following sites: 
 Norway; five specialist palliative care (SPC) inpatient units, four in hospitals 
(35 beds in all) and one in a nursing home (8 beds), one SPC outpatient service 
and one municipal home care service (5 sites in all) 
 France; one SPC service with a 12 bed inpatient unit and outpatient services 
 Italy; one hospital-based SPC team serving both inpatients and outpatients 
 Ireland; one hospice with two inpatient units (43 beds in all) and two day care 
units  
 UK; one hospice (32 beds) 
The centres were recruited through an open invitation presented at palliative care conferences, 
and from established collaborative research networks. Each centre contributed a minimum of 
15 patients to the study. 
In each country, an experienced researcher (MF, MIB, MC, RM, KRS) was responsible for 
recruiting local study coordinators/interviewers. The local study coordinators had different 
professional backgrounds (registered nurse, research nurse, physician, medical student), 
research credentials, and research experience.  
Data were collected in the period September 2015-December 2016. 
 
Translation 
The first version of the EAPC Basic Dataset was developed in English. Translation into the 
native language was performed in France, Norway, and Italy. The national study coordinators 
(MF, MC, KRS) were responsible for the translations. In France, the translation was carried 
out according to the European Organization for Research and Treatment of Cancer (EORTC) 
procedure 21. In Norway and Italy, the translation process involved one forward translation 
from English into the target language by a translator with medical background, good 
command of English, and the target language as his/her native language. The translated 
version of the dataset was then checked by two independent persons fluent in the target 
language and with good knowledge of English, and consensus was reached in case of 
incongruence. Following the translation, the dataset was completed by a small sample of the 
target population to check comprehensibility.  
Two other documents were translated in the same way; ‘Pilot testing the EAPC Basic Dataset: 
structured interview guide’ and ‘Guidelines for using the EAPC Basic Dataset’.  
The qualitative data were translated into English by one of the local study coordinators in 
France. In Italy, data were translated by one physician and reviewed by another. Qualitative 
data from participants in Norway were analysed without being translated. 
Participants 
Participants for the pilot testing were 
1. Patients admitted to palliative care services as described above. Patients were eligible 
for the study if they had incurable cancer, age ≥18 years, and the ability to give informed 
consent. Patients who fulfilled the inclusion criteria, but did not speak the language in 
question, were excluded. Seven of the nine participating study centres screened potential 
participants. The remaining two centres recruited per convenience. 
2. The patient’s responsible health care provider (physician and/or nurse). 
 
Study measures 
With the aim to assess acceptability, comprehensibility, and feasibility of the EAPC Basic 
Dataset, the following information was collected: 
1. Non-participating patients 
Age group, gender, diagnostic group, and the Australia-modified Karnofsky Performance Scale 
(AKPS) 22 score were recorded for all non-participating patients. The reason for not 
participating was noted, using predefined categories. 
2. Participants 
After the included patients had read and signed the consent form, they were asked to complete 
the EAPC basic dataset patient form. The responsible health care provider (physician and/or 
nurse) was asked to complete the health care personnel form. The forms were completed on 
paper, followed by a standard structured interview for both respondent groups, with the 
questions indicated below. By the end of the interview, the participants were asked about the 
layout of the form, if any items were irrelevant, if the sequence of items was appropriate, and 
if they had any other comments about the questionnaire. Only one study entry per patient was 
allowed. Information about the health care provider’s age, gender, profession, and years 
working in palliative care was recorded. 
Acceptability was assessed by asking the participants if they found any question annoying, 
confusing, upsetting, had comments re acceptability, or found the response options unsuitable. 
Poor acceptability for an item was judged if > 10% of participants answered positively to 
these questions, which is a commonly used cut-off in survey pre-testing 20. 
Comprehensibility was determined insufficient if at least 10% of participants found any 
question difficult to respond to, if the answer was obviously incorrect or missing, or if they 
commented on a poorly understandable question or response option. 
Feasibility was judged by how long it took the participants to complete the questionnaire, if 
assistance was needed, and whether the requested information was readily available for the 
health care professionals. The ratio included/non-participating was also measured. 
 
Data analysis 
Data were entered into an online database. Analysis was by mixed methods; quantitative data 
were analyzed using descriptive statistics, and qualitative data by the first author (KRS) using 
content analysis 23. The researcher read all the comments for each item many times before 
dividing the text into meaning units. The next step was to develop codes as descriptive labels 
for the meaning units, before sorting the codes into categories. Afterwards the categories were 
assorted into three groups: comments on difficulties, proposals on how to improve the dataset, 
and other comments. 
Based on the analysis, decisions to change, add, delete, or reword items were made by two of 
the authors (KRS and DFH). 






A total of 544 patients were screened; 353 did not participate or were excluded. Two study 
sites did not screen and recruited per convenience; one did not have access to interviewer on a 
daily basis, and the other was a home care service. Table 1 presents recruitment, 
characteristics of the non-participating patients, and the reasons for not participating. The 
most common reasons given were ‘too unwell’ (26%), ‘not advanced cancer’ (18%), and 
‘unable to give informed consent’ (13%). There were great differences in the ratio 





Altogether, 191 patients participated (Table 1).  
 
Patient characteristics  
The patients’ mean age was 67.6 years, median 69 (range 25-90). Sixty-five percent were ≥ 
65 years old. The most common cancer group for included patients (n=172) was cancer in 
digestive organs (ICD-10 codes C15-26), 24%; followed by breast (C50), 15%; respiratory 
and intrathoracic (C30-39), 14%; male genital organs (C60-63), 13%; and lymphoid and 
hematologic malignancies (C81-96), 9%; 79% had metastatic /disseminated disease, and 36% 
were not receiving anticancer therapy. Seventy-five percent had performance status ≥ 60. 
Further details are given in Tables 2 and 3. 
 
Patient responses 
Median time to fill in the patient form was 5 minutes (range 1-60 minutes). One hundred and 
twenty-eight patients completed the form without assistance. Fifty-five patients required 
assistance; of these 46 received assistance from health care providers, seven from a family 
caregiver or friend, and two from a family caregiver /friend and health care provider. In five 
cases, the form was filled in by health care providers alone, and in two by a family caregiver 
or friend. 
Table 2 shows the number of responses for each variable in the patient part of the dataset, and 
missing data for each item. The most challenging variable for patients was ethnicity. The 
question ‘What is your ethnicity?’ was answered by 127 patients (66%), out of whom 108 
stated their nationalities. Thirty-two patients found the question difficult to respond to, 11 
found the question annoying, confusing, or upsetting, and 37 gave other comments (Figure 2), 
the most common being ‘don’t understand the word ethnicity’. Figure 2 shows the 
participants’ responses to the standardized questions asked by the interviewers, and Table 2 
participants’ comments and suggestions for improvement. Based on these findings, ethnicity 
will be replaced with an open question about nationality in some countries, others will find a 
predefined list appropriate, while yet others will have to exclude this variable.  
Many patients had the same comments for more than one symptom (Table 2). One of the 
remarks was the order of symptoms on the form. Both patients and health care providers 
recommended grouping related symptoms together. 
Age and gender were the only variables without any form of modifications. Living situation 
and highest completed level of education have been modified as shown in Table 2. 
 
Health care professionals  
 
Health care professional characteristics 
One hundred and ninety health care professionals gave information about themselves: Mean 
age was 42.7 years; 165 were females; 103 were physicians, and 84 nurses. The median 
working time within palliative care was six years (range 0-40). Some of the health care 
professionals probably filled in more than one form. 
 
Health care professional responses 
Median time to fill in the health care personnel form was 7 minutes (range 2-195). 
Sixteen health care professionals needed assistance to complete the health care personnel 
form, most commonly nurses needing information from physicians about ICD-10 codes, 
medications, performance status, or cognitive functioning. 
Eight variables were perceived as challenging in the health care personnel part, as based on 
questions about responding difficulties, completion, missing data, and comments: Principal 
diagnosis, date of the principal diagnosis, stage of the cancer disease, additional diagnoses, 
stage of the non-cancer disease, weight loss, place of care, and performance status. Figure 2 
shows the participants’ responses to the standardized questions asked by the interviewers, and 
Table 3 sums up the comments. 
 The principal and additional diagnoses 
The health care personnel were supposed to fill in the principal diagnosis using an ICD-10 
code. ICD-10 codes were used in 59% of cases, and type of cancer using free text in 24%. The 
cancer diagnosis was missing in 11%, while 6% used various other codes. Eighty-seven 
participants found the item difficult to respond to; the most common reason was, ‘don’t know 
the ICD-10 code’ (Table 3). One recommendation for improvement was to make a 
standardized list of cancer diagnoses. As a result, ICD-10 codes will be replaced by a 
standardized list based on ICD chapters and blocks (Table 3).  
Some of the same challenges applied to the additional diagnoses. ICD-10 codes were used in 
83 cases (46 were non-cancer diagnoses, 29 were cancer or metastases, and eight ICD-10 Z or 
R codes). The disease was written as text in 25 cases. The result will be to replace the ICD-10 
code by a standardized list (Table 3). 
 Stage of the non-cancer disease 
Fifty-five patients were distributed between the following categories: New York Heart 
Association (NYHA) Functional Classification class I (19), II (2), III (3), IV (1); Global 
Initiative for Chronic Obstructive Lung Disease (GOLD) stages 1 (10), 2 (4), 3 (1), 4 (4), and 
Functional Assessment Staging (FAST) scale, 1 (10), 2 (1). The response distributions with 
dominance of the first stages caused suspicion about incorrect answers. Sixty-four health care 
professionals reported difficulties completing this item, and the most common comment was; 
‘don’t know the classification systems’ (Table 3). Several participants proposed to exclude 
this variable, or make it optional. This has resulted in removal of the variable. 
 Date of the principal diagnosis 
Date of the principal diagnosis was reported as intended in 138 cases (72%) with month and 
year; 46 with only year, and seven missing. Thirty-nine found the item difficult to respond to, 
and the most common reason was ‘hard to find’. No proposals for change were received. The 
variable will remain unchanged. 
 Weight loss 
Only 38 participants (20%) filled in weight loss in percentage and duration of weight loss in 
months. This item was clearly the most difficult one to respond to (Figure 2). Comments are 
given in Table 3. As a consequence, the variable has been removed.  
 Performance status 
Sixteen percent of the participants found the question difficult to respond to. The most 
common comment was ‘challenging to choose the right category’, and only 59% found the 
response options suitable. Three times two categories were marked. However, there were only 
2% missing data. The AKPS is a validated tool, and in this first version of the dataset it was 
decided not to change the response options. 
 
Date of the principal diagnosis and performance status were the only variables without any 
form of modification. The rest of the variables have been modified as shown in Table 3.  
The layout of the forms was suitable for the majority; however, there were a few comments 
that it was hard to read the black numbers and text on the dark green background. The green 
colour will consequently be changed to a brighter one. 
 
Discussion 
The first version of the EAPC Basic Dataset has been pilot-tested by altogether 381 
individuals from the target groups, in five different European countries. Our results show that 
palliative care cancer patients and health care professionals are willing and able to use the 
dataset. The majority of study participants reported to understand the instructions and 
questions. The following five variables were perceived as most challenging: ethnicity, 
principal diagnosis, additional diagnoses, stage of the non-cancer disease, and weight loss. 
Consequently, the pilot-testing has led to changes in the first official version of the dataset. 
 
Feasibility 
Median time to fill in the form was 7 minutes for health care personnel and 5 minutes for 
patients, and 67% of the patients filled in the form alone. The acceptable time expenditure and 
the fact that two-thirds of the patients completed the form without assistance, support the 
feasibility of the dataset. However, many palliative care cancer patients were unable to 
participate, as only 191 out of 544 were included, with an inclusion rate of 44% for the sites 
that performed screening. The most common reason for not participating was being too 
unwell, confirming that many palliative care cancer patients are frail. The non-participants 
were slightly older and had a lower mean AKPS score than the participants; 53% of the non-
participants had AKPS score ≤ 50, compared to 24% of the included patients. However, we 
believe it is also possible to use the EAPC Basic Dataset for some of these patients. The 
patient part can be completed by a caregiver, and rating of symptoms based either on input 
from the patient or by observer assessment as recommended in Guidelines for using the 
Edmonton Symptom Assessment System revised (ESAS-r) 25. Further testing is required to 
test our assumption. 
Probably, more patients could have been able to complete the dataset and participate in the 
pilot. Stone et al found that gate keeping by clinical staff in palliative care research was the 
second most common reason for inaccessibility, with 24% of eligible patients not available 
for the research team 26. Inaccessibility or unavailability of researcher and eligible patients is 
also an issue. In our material, 17% of the cases not participating were due to this mismatch.  
One can also speculate that the need for interview after completion has been a limitation and 
that in reality there are more patients able to complete the dataset.  
 
Acceptability 
There were very few negative comments regarding acceptability, and few patients reported 
finding questions annoying, confusing or upsetting. The wellbeing item was the one with 
most patients (10%) reporting ‘annoying, confusing or upsetting’. The majority found the 
word and the scale confusing, with best wellbeing as 0 and worst wellbeing as 10. Only one 
patient reported to be upset. No change was made, based on the finding that 96% were able to 
respond to the item; another reason is that the item comes from ESAS-r. ESAS has evolved 
over the last 27 years and is a robust symptom assessment instrument used both in research 
and clinical practice 27. 
We conclude that both patients and health care providers find the EAPC basic dataset 
acceptable for use.  
 
Comprehensibility  
The participants understood the majority of the questions. The frequency of missing answers 
corresponded to the responses that the participants found the item difficult to respond to, 
however, the comments demonstrated that this was not due to finding the questions difficult to 
understand. The main reasons were that information was not available in the patient records, 
e.g. concerning weight, or the respondents did not know or use the ICD-10 system. Ethnicity 
was the item most patients found difficult to understand.  
 
Changes in the EAPC Basic Dataset 
The fact that this pilot study had almost 400 participants gives reason to believe that the 
resulting changes are well founded and will give a better version of the dataset. Five variables 
were found to be most challenging. Two of these, ethnicity and weight loss, were variables on 
which consensus on method of assessment was not achieved in the Delphi process. For the 
purpose of the pilot testing, the research group based their choice of assessment method on 
comments from the Delphi panel 18. However, the pilot testing showed that ethnicity is a 
tricky variable, requiring decisions at a national level about whether or how to include this 
item. For instance, France has a law prohibiting individuals being enumerated by ethnicity 
without their consent or a state committee waiver. 
The use of ICD-10 for principal and additional diagnoses was also problematic. To improve 
the next version, individual coding will be exchanged with a standardized list based on the 
ICD structure. This may be more sensible, as researchers are accustomed to reporting diseases 
in wider categories. Hopefully also clinicians will find this solution more agreeable and less 
time consuming. 
The pilot testing also resulted in some adjustments in response options, both by adding new 
categories and by giving the option to specify in free text when answering ‘other’. Relevant 
symptoms in the patient form have been grouped together, based on feedback from both 
patients and health care providers.  
 
Strength and limitations 
All nine study sites had interviewers without any connection to the development of the EAPC 
Basic Dataset. By using a standardized interview guide we tried to minimize interviewer bias. 
Our study has some limitations. The fact that the translation was not performed according to 
the EORTC translation guidelines 21 in two countries may represent a problem. The reason for 
deviating from these guidelines was that many of the variables within the dataset, and 
especially the PROMs, originate from internationally established and validated tools and 
manuals such as the ESAS-r 28, the AKPS, and ICD-10 29, and were taken from authorized 
translations. The additional items concern objective information only.  
Screening was not performed at all the participating centres. There were big differences in the 
ratio included/ not participating between the study sites, an observation which cannot be 
explained by differences in average age or mean AKPS at the different sites. The reasons are 
probably multifactorial, relating to all the three main ‘bottlenecks’ to recruitment to a 
multicentre palliative care study; eligibility, accessibility and consent, as identified by Stone 
et al 26. The two centres with the highest numbers of non-participating patients were hospices 
with the most beds. However, there were differences in the case mix between the centres. One 
of the centres with the lowest ratio had 20% non-cancer patients in the population, while the 
centre with the highest ratio only served cancer patients. Unavailability of the researcher or 
patient was also more common at the sites with high numbers of non-participating patients. 
The researcher’s personal traits, the way patients were informed and invited to participate, and 
the personal interaction between researcher and clinicians have probably also affected 
inclusion rates. For instance, the recruitment rate improved at one site after the researcher 
recognized the high rate of poor literacy and offered to read the information to the patients. 
Health care personnel were not supposed to participate in the study more than once. 
Unfortunately this was insufficiently addressed in the study protocol. The results indicate that 
some professionals participated more than once, but as this deviation only concerned one of 
nine study sites, we consider it of minor influence. 
Despite the above mentioned limitations, the pilot testing has given results leading to 
rewording, improvements in response options, and removal of items from the dataset. We 
strongly encourage researchers to use the dataset as part of the case report form for studies in 
cancer palliative care, realizing, however, that supplementary modules may be needed for 
specific purposes. Using the dataset in research reporting will lead to a thorough description 
of the study sample, which is a prerequisite for judging the external validity of the study 
results 30. Further work will be needed to test the revised version of the dataset. The EAPC 





The first version of the EAPC basic dataset has undergone pilot-testing confirming that 
patients and health care personnel understand the questions in a consistent manner. The pilot 
testing has led to rewording, changes in response options, and shortening of the dataset, which 
is now ready for use and further testing.  
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       PATIENT FORM 
 What is your: Please fill in or tick the right box as appropriate. 
1 Date of birth (Day.Month.Year) 













With spouse/partner and children 
With children 
With other adult(s) 
In an institution 
Other 
4 Highest completed 











Symptoms. Please mark the number that best describes how you feel NOW: 
6 No Pain 0 1 2 3 4 5 6 7 8 9 10 Worst Possible  
Pain ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
7 No Tiredness 
(Tiredness = lack of energy) 
0 1 2 3 4 5 6 7 8 9 10 Worst Possible  
Tiredness ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
8 No Drowsiness 
(Drowsiness = feeling sleepy) 
0 1 2 3 4 5 6 7 8 9 10 Worst Possible  
Drowsiness ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
9 No Nausea 0 1 2 3 4 5 6 7 8 9 10 Worst Possible 
Nausea ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
10 No Lack of 
Appetite 
0 1 2 3 4 5 6 7 8 9 10 Worst Possible 
Lack of Appetite ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
11 No Shortness 
of Breath 
0 1 2 3 4 5 6 7 8 9 10 Worst Possible 
Shortness of Breath ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
12 No Depression 
(Depression = feeling sad) 
0 1 2 3 4 5 6 7 8 9 10 Worst Possible 
Depression ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
13 No Anxiety 
(Anxiety = feeling nervous) 
0 1 2 3 4 5 6 7 8 9 10 Worst Possible 
Anxiety ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
14 Best Wellbeing 
(Wellbeing = how you feel 
overall) 
0 1 2 3 4 5 6 7 8 9 10 Worst Possible 
Wellbeing ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
15 Best Sleep 0 1 2 3 4 5 6 7 8 9 10 Worst Possible  
Sleep ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
16 No Constipation 0 1 2 3 4 5 6 7 8 9 10 Worst Possible 
Constipation ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
17 No Vomiting 0 1 2 3 4 5 6 7 8 9 10 Worst Possible 
Vomiting ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ ☐ 
 
 
      HEALTH CARE PERSONNEL FORM 
 Patient’s: Please fill in or tick the right box as appropriate 




ICD-10 code   








☐ Locally advanced 
☐ Metastatic/disseminated 
 













☐ Hormone therapy 
☐ Other anticancer therapy 







25 Stage of the 
non-cancer 
disease 
Chronic heart failure (CHF): The New York Heart Association (NYHA) 
Functional Classification; NYHA class: I ☐, II ☐, III ☐ , IV ☐ 
Chronic obstructive pulmonary disease (COPD): GOLD classification; 
stage: I ☐, II ☐, III ☐, IV ☐ 
Dementia: FAST scale; stage: 1 ☐, 2 ☐, 3 ☐, 4 ☐, 5 ☐, 6 ☐, 7 ☐ 
 
26 Medication ☐ Non-opioid analgesics 







☐ Drug(s) for acid related disorders 
 








☐ Heart medication / antihypertensives  
☐ Other  





☐ 100 Normal; no complaints; no evidence of disease. 
☐   90 Able to carry on normal activity; minor signs or symptoms. 
☐   80 Normal activity with effort; some signs or symptoms of disease 
☐   70 Cares for self; unable to carry on normal activity or to do active work. 
☐   60 Requires occasional assistance but is able to care for most of his needs. 
☐   50 Requires considerable assistance and frequent medical care. 
☐   40 In bed more than 50% of the time. 
☐   30 Almost completely bedfast. 
☐   20 Totally bedfast and requiring extensive nursing care by professionals and/or family. 
☐   10 Comatose or barely arousable. 












30 Place of 
care 
☐ Home 
☐ Long-term care facilities 












 Was this question difficult to respond to? 
 Was it annoying, confusing or upsetting? 


















         Was the item difficult to respond to?  




Figure 2. Pilot-testing the EAPC Basic Dataset: The number of patient participants (n=191; A) and 








Table 1. Recruitment to pilot-testing of the EAPC Basic Dataset, characteristics of non-








  Number (%) 
Age groups 25 - 34 years 3 (1) 
35 - 44 years 11 (3) 
45 - 54 years 36 (10) 
55 - 64 years 72 (20) 
65 - 74 years 102 (29) 
75 - 84 years 93 (26) 
85 years and over 34 (11) 
Gender Male 183 (52) 
Female 166 (48) 
Cancer diagnoses by 
site (ICD 10 codes) 
Lip, oral cavity & pharynx (C00-14#) 4 (1) 
Digestive organs (C15-26#) 85 (27) 
Respiratory & intrathoracic (C30-39#) 44 (14) 
Breast (C50#) 52 (16) 
Female genital organs (C51-58#) 14 (4) 
Male genital organs (C60-63#) 23 (7) 
Urinary tract (C64-68#) 13 (4) 
544 patients eligible for screening 
353 non-participating patients 
 France  45 
 Ireland  109 
 Italy  26 
 Norway  80 
 UK  93 
191 included patients 
 France 45   
 Ireland  21 
 Italy  20 
 Norway  90 
 UK  15 





Eye, brain & CNS (C69-72#) 16 (5) 
Lymphoid, haematopoietic (C81-96#) 34 (11) 
Other specified sites (C40-49, and 73-75#) 15 (5) 
Independent multiple sites (C97#) 1 (0) 
Ill-defined, secondary, unspecified including 
carcinomatosis (C76-80#) 
11 (3) 
Not recorded 5 (2) 
Non-cancer diagnoses 
(ICD-10 codes) 
Motor neurone disease (G12#) 6 (3) 
Neurological conditions (G00-99#), excluding G12# and G30# 11 (5) 
Dementia including Alzheimer's disease 
(G30 and other, F00-03#) 
5 (2) 
Heart failure (I50#) 17 (7) 
Other heart and circulatory conditions 
(I00-99, excluding I50#) 
40 (17) 
Chronic respiratory disease (J40-70#) 28 (12) 
Chronic renal failure (N18#) 13 (5) 
All other non-cancer diagnoses 45 (19) 
Diagnosis not recorded 72 (30) 
Patient's performance 
status 
100 Normal; no complaints; no evidence of 
disease 
8 (2) 
90 Able to carry on normal activity; minor signs or symptoms 28 (8) 
80 Normal activity with effort; some signs or 
symptoms of disease 
26 (8) 
70 Cares for self; unable to carry on normal activity or to do active 
work 
31 (9) 
60 Requires occasional assistance but is able to care for most of his 
needs 
66 (19) 
50 Requires considerable assistance and frequent medical care. 72 (21) 
40 In bed more than 50% of the time 35 (10) 
30 Almost completely bedfast 25 (7) 
20 Totally bedfast and requiring extensive 
nursing care by professionals and/or family 
41 (12) 
10 Comatose or barely arousable 8 (2) 
Reason for not 
participating 
Not advanced cancer 67 (18) 
Unable to give informed consent 46 (13) 
Has already participated in the pilot-testing 6 (2) 
Too unwell 92 (26) 
Patient ‘didn’t want to’/ ‘Not interested’ 33 (9) 
Weekend/evening admission (researcher unavailable) 25 (7) 
Declined consent, reason unknown 21 (6) 
Other, please specify* 64 (18) 
*Other; attends daycare on a day researcher is not available (24), time issues (lack of time, patient had 
left before researcher had time) (12), mental health issues (5), speech difficulties (4), does not speak 














Table 2. Results of pilot-testing the EAPC Basic Dataset patient form: Characteristics of the included patients (n=191); number of responses and 
missing data for each item; qualitative responses grouped as comments on difficulties and proposals for improvement; resulting changes made to 
the dataset.   
Patient form Number of 
responses 
(%) 
Mean (range) Missing 




Proposals on how to 
improve the dataset 
Resulting changes in the 
EAPC Basic Dataset 
Age  191 (100) 67.6 (25-90)     
Gender Male 97 (51)      
Female 94 (49)  
Living situation  
 
Alone 59 (31)  2 (1) Living with adult child  
A temporary stay in an 
institution 
Define a child (< 18 years 
old)  
Specify living situation as 
NOW 
Current living situation  
With spouse / partner and 
children (< 18 years old) 
With children (< 18 years old) 
With spouse/partner 70 (37)  
With spouse / partner 
and children  
33 (17)  
With children 4 (2)  
With other adult(s) 9 (5)  
In an institution 4 (2)  
Other  13 (7)  
Highest completed 
level of education  
 
Primary school 43 (22)  2 (1) Education was completed 
long ago, and schools and 
systems have changed  
To add one more 





Secondary school / 
high school  
87 (45)  
College/university  65 (34)  
4 patients had vocational 
training and missed an 
option for that 
2 patients had not 
completed primary 
education 
Ethnicity   127 (66)  64 (33) Don’t  understand the 
word ethnicity, what it 
means  
Didn’t understand the 
question  
Unsure about what to 
answer 
Ask for nationality instead 
of ethnicity  
To use tick boxes with 
predefined categories 
Nationality 
Predefined categories at the  
national level  
Symptoms Pain 191 (100) 3.1 (0-10)  Many patients had the 
same comments for more 
than one symptom. The 
comments could be 
categorized into the 
following:  
- Difficult to quantify 
symptom and to use 
numerical rating 
scale 
- Using the time 
frame now when 
symptoms fluctuate  
To change the order of 
symptoms 
Pain 
Shortness of Breath  
Tiredness 
Drowsiness 





Tiredness  183 (96) 4.8 (0-10) 8 (4) 
Drowsiness  187 (98) 3.7 (0-10) 4 (2) 
Nausea  188 (98) 1.2 (0-8) 3 (2) 
Lack of Appetite  190 (99) 3.2 (0-10) 1 (1) 
Shortness of Breath  189 (99) 2.9 (0-10) 2 (1) 
Depression  188 (98) 2.5 (0-10) 3 (2) 
Anxiety  187 (98) 2.4 (0-10) 4 (2) 
Wellbeing  184 (96) 3.9 (0-10) 7 (4) 
Sleep  186 (97) 3.3 (0-10) 5 (3) - Difficult to 
differentiate between 
symptoms 
- Understanding and 
meaning of words  





Constipation  188 (98) 2.9 (0-10) 3 (2) 













Table 3. Results of pilot-testing the EAPC Basic Dataset health care personnel form: Medical variables for the included patients;  number of 
responses and missing data for each item; qualitative responses grouped as comments on difficulties and proposals for improvement; and 
resulting changes made to the dataset.   




data,   
Number (%) 
Comments on difficulties Proposals on how to 
improve the dataset 




ICD-10 code 113 (59)  21 (11) Don’t know the ICD-10 code  
Hard to find  
Don’t use it 
Only used in hospitals 
Only used in death certificates 
Time-consuming  to find the code 
Write the diagnosis 
Use a standardized list of 
cancer diagnoses  
□ Malignant neoplasms of lip, oral cavity 
and pharynx  (C00-14#) 
□ Malignant neoplasms of digestive 
organs  (C15-26#) 
□ Malignant neoplasms of respiratory 
and intrathoracic organs ( C30-39#) 
□ Malignant neoplasms of bone and 
articular cartilage ( C40-41 #) 
□ Melanoma and other malignant 
neoplasms of skin  (C43-44#) 
□ Malignant neoplasms of mesothelial 
and soft tissue  (C45-49#) 
□ Malignant neoplasm of breast  (C50#) 
□ Malignant neoplasms of female genital 
organs  (C51-58#) 
□ Malignant neoplasms of male genital 
organs  (C60-63#) 
□ Malignant neoplasms of urinary tract  
(C64-68#) 
□ Malignant neoplasms of eye, brain and 
other parts of central nervous system  
(C69-72#) 
□ Malignant neoplasms of thyroid and 
other endocrine glands  (C73-75#) 
□ Malignant neoplasms of ill-defined, 
secondary and unspecified sites  (C76-
80#) 
□ Malignant neoplasms, stated or 
presumed to be primary, of lymphoid, 
haematopoietic and related tissue  (C81-
96#) 
□ Malignant neoplasms of independent 
(primary) multiple sites (C97#) 
□ Benign neoplasms  (D10-36#) 
□ Neoplasms of uncertain or unknown 
behaviour (D37-48#)   
Date of the 
principal 
diagnosis 
Month. Year 138 (72)  7 (4) Hard to find, especially the month 
Need to look for it  
Time-consuming  to find 
  
Stage of the 
cancer disease  
Local 12 (6) 4 (2) Hard to find 
Hematologic cancer 
Now or at the time of diagnosis 
Don’t know the difference between 
local and locally advanced 
Specify now 
Specify solid cancer disease 
Add no/missing information 
Current stage of the cancer disease 
Locally advanced 27 (14) 
Metastatic/disseminated  152 (79) 
Site of 
metastases  
Bone  76 (40)  Hard to find 
Now or at the time of diagnosis 
Add lymph nodes 
The possibility to specify other 
using free text 
Other, please specify _________ 
Liver  62 (32) 
Lung  61 (32) 
CNS  18 (9) 




Radiotherapy 38 (20) 2 (1) Difficult to find out what is meant 
by present, some of the patients 
had a pause from treatment 
Add surgery 




Other anticancer therapy, please specify 
_______________ 
Chemotherapy 75 (39) 
Hormone therapy 24 (12) 
Other anticancer therapy  11 (6) 
No anticancer therapy  69 (36) 
Additional 
diagnoses  
ICD-10 83 (43)   Don’t know ICD-10 
Don’t use ICD-10 
Hard to find 
Time consuming  
Use standardized list of 
relevant diagnoses 
To be able to write out the 
name of the diseases 
Opportunity to tick Yes or No 
Additional diagnoses ( other diagnoses 
than the cancer diagnose, having 
substantial impact on the patient’s 
health) 
What is meant by additional 
diagnose 
To specify in the text what is 
meant by additional diagnoses 
□ Certain infectious or parasitic diseases  
(A00-B99#) 
□ Neoplasms  (C00-D48#)  
□ Diseases of the blood or blood-forming 
organs and certain disorders involving 
the immune mechanism  (D50-89#)   
□ Endocrine, nutritional or metabolic 
diseases  (E00-90#) 
□ Mental and  behavioural disorders  
(F00-99#) 
□  Diseases of the nervous system  
(G00-99#) 
□ Diseases of the eye and adnexa  
(H00-59#) 
□  Diseases of the ear or mastoid 
process  (H60-95#) 
□  Diseases of the circulatory system  
(I00-99#) 
□ Diseases of the respiratory system  
(J00-99#) 
□  Diseases of the digestive system  
(K00-93#) 
□  Diseases of the skin and 
subcutaneous tissue  (L00-99) 
□ Diseases of the musculoskeletal 
system or connective tissue  (M00-99#) 
□ Diseases of the genitourinary system  
(N00-99#) 
Stage of the non-
cancer disease  
 
Chronic heart failure 
(CHF): The New York 
Heart Association (NYHA) 
Functional Classification; 
NYHA class  I - IV  
25 (13)   Don’t know the classification 
systems  
Hard to find 
Too complicated 
Exclude it from the dataset  





classification; stage I - IV  
19 (10)  
Dementia: FAST scale; 
stage: 1 - 7   
11 (6)  
Medication  Non-opioid analgesics  108 (56)  Information not available  
Difficult to place drugs in 
categories 
Uncertainty about the medication, 
if it is by the clock or as needed or 
both 
To add new categories; no 




Others have the opportunity to 




Other, please specify 
_____________________ 
 
Opioids 129 (67) 
Co-analgesics 39 (20) 
Corticosteroids  84 (44) 
Antidepressants 43 (22) 
Antiemetics 75 (39) 
Neuroleptics 22 (11) 
Sedatives/anxiolytics 63 (33) 
Drug(s) for acid related 
disorders  
94 (49) 
Laxatives  119 (62) 
Antibiotics 24 (12) 
Diuretics 34 (18) 
Heart medication / 
antihypertensives  
50 (26) 
Other  78 (41) 
Weight loss  Involuntary weight loss 
____ % and duration of 
weight loss ____months 
38 (20)  153 (80) No routine for weighing patients 
Information not available  
Difficult to use percentage 
To use kilograms instead of 
percentage 
Fixed timeframe over 6 
months  





100 Normal; no 
complaints; no evidence of 
disease. 
4 (2) 3 (2) Challenging to choose the right 
category, did not fit the case 
Accustomed to use WHO/ECOG 
scale 
To use combined 
ECOG/Karnofsky scale 
 
90 Able to carry on normal 
activity; minor signs or 
symptoms. 
22 (11) 
80 Normal activity with 
effort; some signs or 
symptoms of disease. 
31 (16) 
70 Cares for self; unable 
to carry on normal activity 
or to do active work. 
41 (21) 
60 Requires occasional 
assistance but is able to 
care for most of his needs. 
47 (25) 
50 Requires considerable 
assistance and frequent 
medical care. 
28 (15) 
40 In bed more than 50% 
of the time. 
8 (4) 
30 Almost completely 
bedfast. 
8 (4) 
20 Totally bedfast and 
requiring extensive 




10 Comatose or barely 
arousable. 
 
0 Dead  
Cognitive function  
The patient has 
cognitive 
impairment;  
No 160 (84) 2 (1) Lack of definitions 
No formal assessment, only based 
on clinical judgment 
Fluctuates 
Add “fluctuating cognitive 
impairment = delirium”   
Fluctuating cognitive impairment added 
Mild 27 (14) 
Moderate  2 (1) 
Severe   
Place of care  Home 60 (31) 3 (2) Usual or now Specify current 
Specify only one option 
Place of current care 
Other, please specify 
________________ 
Long-term care facilities 2 (1) 
Hospice / Palliative care 
unit  
75 (39) 
Hospital 65 (34) 
Other  2 (1) 
Provision of care  
 
Inpatient  93 (49) 2 (1) What is the difference between 
outpatient and day care? 
Specify current Provision of current care 
Outpatient  63 (33) 
Day care  33 (17) 
#ICD-10 code 
 
